NHS Generic Pharmaceuticals - Wave 16c

NHS England

Value
£576,000,000
Published
4 Sept 2026
Deadline
Not stated
Procedure
Open procedure
Category
33600000 — Pharmaceutical products
Location
UKC, United Kingdom
Notice reference
083835-2026

Requirements summary

NHS England is planning an open-procedure framework procurement for Wave 16c NHS generic pharmaceuticals, covering oral products for the London South and North East (DLS & DNE) regions and housekeeping products for the remaining regions. The notice gives an estimated value of GBP 480m excluding VAT (GBP 576m gross), with a contract period from 1 June 2028 to 31 May 2030 and a maximum extent to 31 May 2032. Commencement and award are subject to budgetary approval.

Key requirements

  • Supply of oral generic pharmaceutical products for the London South and North East (DLS & DNE) regions under Wave 16c
  • Supply of housekeeping products for the remaining regions in scope, which the notice's delivery addresses list as all nine English regions
  • Framework agreement with a contract period from 1 June 2028 to 31 May 2030, extendable to 31 May 2032 with a renewal option
  • Estimated value of GBP 480m excluding VAT (GBP 576m gross)
  • SME suitability indicated for the lot
  • Planned procurement: procurement and award are subject to budgetary approval, and a future notice is expected by 6 September 2027
NHS Generic Pharmaceuticals - Wave 16c — NHS England | ProposAI